On December 28, 2016, the U.S. Food and Drug Administration (FDA) released final guidance on the management of cybersecurity vulnerabilities for marketed and distributed medical devices. The guidance establishes a risk-based approach for the reporting of medical device cybersecurity vulnerabilities to the FDA.… Continue reading
On Tuesday, October 6, 2015, Norton Rose Fulbright attorneys Boris Segalis, Mark Faccenda and Kimberly Gold will present a health information privacy and security web seminar focused on compliance risks and obligations surrounding connected medical devices and healthcare data.… Continue reading